Lenalidomide and Rituximab in Treating Patients With Recurrent and/or Refractory Multiple Myeloma
Clinical trial NCT00567229 · TERMINATED
Trial details
- NCT number
- NCT00567229
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-11-01
- Primary completion
- 2009-02-01
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.